Dopamine agonists and Parkinson's disease progression: what can we learn from neuroimaging studies

Ann Neurol. 2003:53 Suppl 3:S160-6; discussion S166-9. doi: 10.1002/ana.10486.
No abstract available

Publication types

  • Review

MeSH terms

  • Clinical Trials as Topic
  • Corpus Striatum / blood supply*
  • Corpus Striatum / metabolism*
  • Disease Progression
  • Dopamine / metabolism
  • Dopamine Agonists / adverse effects
  • Dopamine Agonists / therapeutic use*
  • Dyskinesia, Drug-Induced / etiology
  • Humans
  • Parkinson Disease / drug therapy*
  • Parkinson Disease / metabolism*
  • Radiopharmaceuticals / pharmacokinetics
  • Substantia Nigra / blood supply*
  • Substantia Nigra / metabolism*
  • Tomography, Emission-Computed*
  • Tomography, Emission-Computed, Single-Photon*

Substances

  • Dopamine Agonists
  • Radiopharmaceuticals
  • Dopamine